Home

WAYNE BURRIS

CIK 1885420 · last filed 2026-06-12

WAYNE BURRIS is a corporate insider who has filed 13 SEC Form 4 insider transactions across 2 companies since 2021. The most recent filing, for OFIX, was dated Jun 12, 2026. Current disclosed insider exposure totals $682.2K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$682.2K

Companies

2

Total Filings

13

Lifetime Open-Market Net

$0

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
OFIX Director 65,504 $10.41 $682.2K $0 7 2026-06-12
Accelerate Diagnostics, Inc (AXDX) Delisted Director 1,678 $0.03 $57 $0 6 2024-06-03

Recent Filings

13 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-12 OFIX Grant (A) +14,965 $0 EDGAR
2025-06-23 OFIX Grant (A) +18,841 $0 EDGAR
2024-06-20 OFIX Grant (A) +15,152 $195.0K EDGAR
2024-06-03 Accelerate Diagnostics, Inc (AXDX) Delisted Exer (M) +839 $0 EDGAR
2024-05-21 Accelerate Diagnostics, Inc (AXDX) Delisted Grant (A) — $0 EDGAR
2023-12-20 OFIX Grant (A) — $0 EDGAR
2023-06-29 Accelerate Diagnostics, Inc (AXDX) Delisted Grant (A) — $0 EDGAR
2023-06-21 OFIX Grant (A) +10,163 $0 EDGAR
2023-06-01 Accelerate Diagnostics, Inc (AXDX) Delisted Exer (M) +8,392 $0 EDGAR
2023-06-01 Accelerate Diagnostics, Inc (AXDX) Delisted Grant (A) — $0 EDGAR
Showing 1–10 of 13
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.